Melanoma Skin Cancer Diagnostic Testing Market, Global Outlook and Forecast 2023-2028

Report ID: 1212918 | Published Date: Jan 2025 | No. of Page: 62 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Melanoma Skin Cancer Diagnostic Testing Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Melanoma Skin Cancer Diagnostic Testing Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Melanoma Skin Cancer Diagnostic Testing Overall Market Size
    2.1 Global Melanoma Skin Cancer Diagnostic Testing Market Size: 2021 VS 2028
    2.2 Global Melanoma Skin Cancer Diagnostic Testing Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Melanoma Skin Cancer Diagnostic Testing Players in Global Market
    3.2 Top Global Melanoma Skin Cancer Diagnostic Testing Companies Ranked by Revenue
    3.3 Global Melanoma Skin Cancer Diagnostic Testing Revenue by Companies
    3.4 Top 3 and Top 5 Melanoma Skin Cancer Diagnostic Testing Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Melanoma Skin Cancer Diagnostic Testing Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Melanoma Skin Cancer Diagnostic Testing Players in Global Market
        3.6.1 List of Global Tier 1 Melanoma Skin Cancer Diagnostic Testing Companies
        3.6.2 List of Global Tier 2 and Tier 3 Melanoma Skin Cancer Diagnostic Testing Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Melanoma Skin Cancer Diagnostic Testing Market Size Markets, 2021 & 2028
        4.1.2 Biopsy
        4.1.3 Imaging
        4.1.4 Others
    4.2 By Type - Global Melanoma Skin Cancer Diagnostic Testing Revenue & Forecasts
        4.2.1 By Type - Global Melanoma Skin Cancer Diagnostic Testing Revenue, 2017-2022
        4.2.2 By Type - Global Melanoma Skin Cancer Diagnostic Testing Revenue, 2023-2028
        4.2.3 By Type - Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Melanoma Skin Cancer Diagnostic Testing Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Dermatology Clinics
        5.1.4 Diagnostic Laboratories
        5.1.5 Others
    5.2 By Application - Global Melanoma Skin Cancer Diagnostic Testing Revenue & Forecasts
        5.2.1 By Application - Global Melanoma Skin Cancer Diagnostic Testing Revenue, 2017-2022
        5.2.2 By Application - Global Melanoma Skin Cancer Diagnostic Testing Revenue, 2023-2028
        5.2.3 By Application - Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Melanoma Skin Cancer Diagnostic Testing Market Size, 2021 & 2028
    6.2 By Region - Global Melanoma Skin Cancer Diagnostic Testing Revenue & Forecasts
        6.2.1 By Region - Global Melanoma Skin Cancer Diagnostic Testing Revenue, 2017-2022
        6.2.2 By Region - Global Melanoma Skin Cancer Diagnostic Testing Revenue, 2023-2028
        6.2.3 By Region - Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Melanoma Skin Cancer Diagnostic Testing Revenue, 2017-2028
        6.3.2 US Melanoma Skin Cancer Diagnostic Testing Market Size, 2017-2028
        6.3.3 Canada Melanoma Skin Cancer Diagnostic Testing Market Size, 2017-2028
        6.3.4 Mexico Melanoma Skin Cancer Diagnostic Testing Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Melanoma Skin Cancer Diagnostic Testing Revenue, 2017-2028
        6.4.2 Germany Melanoma Skin Cancer Diagnostic Testing Market Size, 2017-2028
        6.4.3 France Melanoma Skin Cancer Diagnostic Testing Market Size, 2017-2028
        6.4.4 U.K. Melanoma Skin Cancer Diagnostic Testing Market Size, 2017-2028
        6.4.5 Italy Melanoma Skin Cancer Diagnostic Testing Market Size, 2017-2028
        6.4.6 Russia Melanoma Skin Cancer Diagnostic Testing Market Size, 2017-2028
        6.4.7 Nordic Countries Melanoma Skin Cancer Diagnostic Testing Market Size, 2017-2028
        6.4.8 Benelux Melanoma Skin Cancer Diagnostic Testing Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Melanoma Skin Cancer Diagnostic Testing Revenue, 2017-2028
        6.5.2 China Melanoma Skin Cancer Diagnostic Testing Market Size, 2017-2028
        6.5.3 Japan Melanoma Skin Cancer Diagnostic Testing Market Size, 2017-2028
        6.5.4 South Korea Melanoma Skin Cancer Diagnostic Testing Market Size, 2017-2028
        6.5.5 Southeast Asia Melanoma Skin Cancer Diagnostic Testing Market Size, 2017-2028
        6.5.6 India Melanoma Skin Cancer Diagnostic Testing Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Melanoma Skin Cancer Diagnostic Testing Revenue, 2017-2028
        6.6.2 Brazil Melanoma Skin Cancer Diagnostic Testing Market Size, 2017-2028
        6.6.3 Argentina Melanoma Skin Cancer Diagnostic Testing Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Revenue, 2017-2028
        6.7.2 Turkey Melanoma Skin Cancer Diagnostic Testing Market Size, 2017-2028
        6.7.3 Israel Melanoma Skin Cancer Diagnostic Testing Market Size, 2017-2028
        6.7.4 Saudi Arabia Melanoma Skin Cancer Diagnostic Testing Market Size, 2017-2028
        6.7.5 UAE Melanoma Skin Cancer Diagnostic Testing Market Size, 2017-2028
7 Players Profiles
    7.1 Myriad Genetics
        7.1.1 Myriad Genetics Corporate Summary
        7.1.2 Myriad Genetics Business Overview
        7.1.3 Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Major Product Offerings
        7.1.4 Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Revenue in Global Market (2017-2022)
        7.1.5 Myriad Genetics Key News
    7.2 Abbott Laboratories
        7.2.1 Abbott Laboratories Corporate Summary
        7.2.2 Abbott Laboratories Business Overview
        7.2.3 Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Major Product Offerings
        7.2.4 Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Revenue in Global Market (2017-2022)
        7.2.5 Abbott Laboratories Key News
    7.3 Foundation Medicine
        7.3.1 Foundation Medicine Corporate Summary
        7.3.2 Foundation Medicine Business Overview
        7.3.3 Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Major Product Offerings
        7.3.4 Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Revenue in Global Market (2017-2022)
        7.3.5 Foundation Medicine Key News
    7.4 Pathway Genomics Corporation
        7.4.1 Pathway Genomics Corporation Corporate Summary
        7.4.2 Pathway Genomics Corporation Business Overview
        7.4.3 Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Major Product Offerings
        7.4.4 Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Revenue in Global Market (2017-2022)
        7.4.5 Pathway Genomics Corporation Key News
    7.5 Cancer Genetics
        7.5.1 Cancer Genetics Corporate Summary
        7.5.2 Cancer Genetics Business Overview
        7.5.3 Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Major Product Offerings
        7.5.4 Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Revenue in Global Market (2017-2022)
        7.5.5 Cancer Genetics Key News
    7.6 Castle Biosciences
        7.6.1 Castle Biosciences Corporate Summary
        7.6.2 Castle Biosciences Business Overview
        7.6.3 Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Major Product Offerings
        7.6.4 Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Revenue in Global Market (2017-2022)
        7.6.5 Castle Biosciences Key News
    7.7 NeoGenomics
        7.7.1 NeoGenomics Corporate Summary
        7.7.2 NeoGenomics Business Overview
        7.7.3 NeoGenomics Melanoma Skin Cancer Diagnostic Testing Major Product Offerings
        7.7.4 NeoGenomics Melanoma Skin Cancer Diagnostic Testing Revenue in Global Market (2017-2022)
        7.7.5 NeoGenomics Key News
    7.8 Dermtech
        7.8.1 Dermtech Corporate Summary
        7.8.2 Dermtech Business Overview
        7.8.3 Dermtech Melanoma Skin Cancer Diagnostic Testing Major Product Offerings
        7.8.4 Dermtech Melanoma Skin Cancer Diagnostic Testing Revenue in Global Market (2017-2022)
        7.8.5 Dermtech Key News
    7.9 Sysmex Inostics
        7.9.1 Sysmex Inostics Corporate Summary
        7.9.2 Sysmex Inostics Business Overview
        7.9.3 Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Major Product Offerings
        7.9.4 Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Revenue in Global Market (2017-2022)
        7.9.5 Sysmex Inostics Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Melanoma Skin Cancer Diagnostic Testing Market Opportunities & Trends in Global Market
    Table 2. Melanoma Skin Cancer Diagnostic Testing Market Drivers in Global Market
    Table 3. Melanoma Skin Cancer Diagnostic Testing Market Restraints in Global Market
    Table 4. Key Players of Melanoma Skin Cancer Diagnostic Testing in Global Market
    Table 5. Top Melanoma Skin Cancer Diagnostic Testing Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Melanoma Skin Cancer Diagnostic Testing Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Melanoma Skin Cancer Diagnostic Testing Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Melanoma Skin Cancer Diagnostic Testing Product Type
    Table 9. List of Global Tier 1 Melanoma Skin Cancer Diagnostic Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Melanoma Skin Cancer Diagnostic Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Melanoma Skin Cancer Diagnostic Testing Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Melanoma Skin Cancer Diagnostic Testing Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Melanoma Skin Cancer Diagnostic Testing Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Melanoma Skin Cancer Diagnostic Testing Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Melanoma Skin Cancer Diagnostic Testing Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Melanoma Skin Cancer Diagnostic Testing Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2023-2028
    Table 30. Myriad Genetics Corporate Summary
    Table 31. Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Product Offerings
    Table 32. Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Revenue (US$, Mn), (2017-2022)
    Table 33. Abbott Laboratories Corporate Summary
    Table 34. Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Product Offerings
    Table 35. Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Revenue (US$, Mn), (2017-2022)
    Table 36. Foundation Medicine Corporate Summary
    Table 37. Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Product Offerings
    Table 38. Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Revenue (US$, Mn), (2017-2022)
    Table 39. Pathway Genomics Corporation Corporate Summary
    Table 40. Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Product Offerings
    Table 41. Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Revenue (US$, Mn), (2017-2022)
    Table 42. Cancer Genetics Corporate Summary
    Table 43. Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Product Offerings
    Table 44. Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Revenue (US$, Mn), (2017-2022)
    Table 45. Castle Biosciences Corporate Summary
    Table 46. Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Product Offerings
    Table 47. Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Revenue (US$, Mn), (2017-2022)
    Table 48. NeoGenomics Corporate Summary
    Table 49. NeoGenomics Melanoma Skin Cancer Diagnostic Testing Product Offerings
    Table 50. NeoGenomics Melanoma Skin Cancer Diagnostic Testing Revenue (US$, Mn), (2017-2022)
    Table 51. Dermtech Corporate Summary
    Table 52. Dermtech Melanoma Skin Cancer Diagnostic Testing Product Offerings
    Table 53. Dermtech Melanoma Skin Cancer Diagnostic Testing Revenue (US$, Mn), (2017-2022)
    Table 54. Sysmex Inostics Corporate Summary
    Table 55. Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Product Offerings
    Table 56. Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Melanoma Skin Cancer Diagnostic Testing Segment by Type in 2021
    Figure 2. Melanoma Skin Cancer Diagnostic Testing Segment by Application in 2021
    Figure 3. Global Melanoma Skin Cancer Diagnostic Testing Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Melanoma Skin Cancer Diagnostic Testing Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Melanoma Skin Cancer Diagnostic Testing Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Melanoma Skin Cancer Diagnostic Testing Revenue in 2021
    Figure 8. By Type - Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Melanoma Skin Cancer Diagnostic Testing Revenue Market Share, 2017-2028
    Figure 12. US Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Melanoma Skin Cancer Diagnostic Testing Revenue Market Share, 2017-2028
    Figure 16. Germany Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2017-2028
    Figure 17. France Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Melanoma Skin Cancer Diagnostic Testing Revenue Market Share, 2017-2028
    Figure 24. China Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2017-2028
    Figure 28. India Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Melanoma Skin Cancer Diagnostic Testing Revenue Market Share, 2017-2028
    Figure 30. Brazil Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Revenue Market Share, 2017-2028
    Figure 33. Turkey Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2017-2028
    Figure 37. Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. NeoGenomics Melanoma Skin Cancer Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Dermtech Melanoma Skin Cancer Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
62
Frequently Asked Questions
Melanoma Skin Cancer Diagnostic Testing Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Melanoma Skin Cancer Diagnostic Testing Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Melanoma Skin Cancer Diagnostic Testing Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports